Medicare Enrolled
Dr. Yasha Modi, M.D.
Ophthalmology · Cleveland, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Modi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Modi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Modi
Dr. Yasha Modi is an ophthalmology specialist in Cleveland, OH, with 15 years of NPI registration. Based on federal Medicare data, Dr. Modi performed 15,077 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Modi received a total of $225,018 from 34 pharmaceutical and/or device companies across 336 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Modi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 7% volume in OH
$225,018 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗15,077
Medicare services
Top 7% in OH for ophthalmology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
7,923 | $28 | $67 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,796 | $34 | $205 |
| Aflibercept eye injection (Eylea) | 1,040 | $684 | $1,429 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
900 | $21 | $98 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
781 | $106 | $781 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $109 | $380 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
470 | $100 | $422 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $76 | $280 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
322 | $159 | $848 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
239 | $78 | $187 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
186 | $56 | $250 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
166 | $27 | $188 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
114 | $56 | $316 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
58 | $32 | $214 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
57 | $131 | $631 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $138 | $746 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
29 | $710 | $5,164 |
| Eye exam using endoscope An examination of the eye performed using an endoscope, which is a thin, lighted tube inserted into the eye to view internal structures. |
22 | $76 | $100 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
20 | $43 | $448 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
12 | $300 | $2,335 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
11 | $14 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$225,018
Total received (2018-2024)
Avg $32,145/year across 7 years
Top 3% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
336
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$60,556
2023
$66,107
2022
$47,873
2021
$7,387
2020
$9,684
2019
$21,212
2018
$12,199
Payments by company (2024)
Hoffmann-La Roche Limited
$16,962
EyePoint Pharmaceuticals US, Inc.
$12,785
Carl Zeiss Meditec USA, Inc.
$9,032
ABBVIE INC.
$7,848
Genentech USA, Inc.
$7,098
Carl Zeiss Meditec, Inc.
$4,080
Regeneron Pharmaceuticals, Inc.
$1,745
Apellis Pharmaceuticals, Inc.
$378
Regeneron Healthcare Solutions, Inc.
$153
Alcon Vision LLC
$102
Astellas Pharma US Inc
$98
Bausch & Lomb Americas Inc.
$87
Janssen Pharmaceuticals, Inc
$60
Astellas Pharma Global Development
$41
Genentech, Inc.
$32
Harrow Eye, LLC
$25
Alimera Sciences, Inc.
$16
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
Hoffmann-La Roche Limited
$48,087
Genentech USA, Inc.
$24,208
Allergan Inc.
$20,171
EyePoint Pharmaceuticals US, Inc.
$17,432
Carl Zeiss Meditec, Inc.
$15,189
Alcon Vision LLC
$14,937
ABBVIE INC.
$14,111
Astellas Pharma US Inc
$11,049
Dutch Ophthalmic, USA
$10,830
Carl Zeiss Meditec USA, Inc.
$9,162
Apellis Pharmaceuticals, Inc.
$6,664
Genentech, Inc.
$6,456
Bausch & Lomb Americas Inc.
$4,922
Regeneron Pharmaceuticals, Inc.
$4,800
Novartis Pharmaceuticals Corporation
$4,464
Alimera Sciences, Inc.
$3,840
Allergan, Inc.
$3,592
Alcon Research LLC
$2,120
Regeneron Healthcare Solutions, Inc.
$1,708
Bausch & Lomb, a division of Bausch Health US, LLC
$217
Alcon Laboratories Inc
$150
Spark Therapeutics, Inc.
$125
Penumbra, Inc.
$123
NEW WORLD MEDICAL,INC.
$122
Ocular Therapeutix, Inc.
$111
Johnson & Johnson Surgical Vision, Inc.
$104
Mallinckrodt Hospital Products Inc.
$69
Janssen Pharmaceuticals, Inc
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Astellas Pharma Global Development
$41
Notal Vision, Inc.
$34
Harrow Eye, LLC
$25
Horizon Therapeutics plc
$25
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · AcrySof IQ PanOptix · AcrySof Toric Aspheric UV Absorbing IOL · Ahmed Glaucoma Valve · BEOVU · BROLUCIZUMAB · CIRRUS HD-OCT · CLARUS · CLARUS 700 · Catalys Laser System · Clareon · Constellation · DAILIES · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · DURYSTA · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · FORUM · ILUVIEN · Iluvien · Indigo System · Izervay · LUMERA 700 · LUXTURNA · Lucentis · NGENUITY · Non-Covered Product · OPMI Lumera · OZURDEX · PURIFIED CORTROPHIN GEL · RETISERT · Rocklatan · STELLARIS · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · Vabysmo · VisuMax · Wavelight · XIPERE · YUTIQ · combined machine
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Modi is a mixed practice specialist, with above-average Medicare volume (top 7% in OH), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Modi experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Modi performed 7,923 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Modi receive payments from pharmaceutical companies?
Yes. Dr. Modi received a total of $225,018 from 34 companies across 336 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Modi's costs compare to other ophthalmologists in Cleveland?
Dr. Modi's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Modi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Cleveland
Browse ophthalmologists in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in OH
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in OH
Which OH ophthalmologists receive the most from drug and device companies.
By company
Hoffmann-La Roche Limited Payments to Doctors
See all physicians who received payments from Hoffmann-La Roche Limited.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology